Report Materials
This report consolidates the results of our reviews of seven selected Medicare Part B providers in California and Hawaii that billed Medicare for Neulasta injections. For 105 Medicare claims reviewed, the 7 providers billed Medicare for the incorrect number of service units of Neulasta. Consequently, during calendar years 2004 through 2007, Part B carriers overpaid these providers $194,000.
Notice
This report may be subject to section 5274 of the National Defense Authorization Act Fiscal Year 2023, 117 Pub. L. 263.